Skip to content
Screener

Vistagen Therapeutics, Inc. VTGN Q3 2025 earnings

Reported November 13, 2025 · After market close

Revenue$258.0KBeat by $112.2K
EPS-$0.54Miss by $0.03
Revenue estimate$145.8K
EPS estimate-$0.51

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$500.0K
EPS estimate-$0.37

FAQ

When did Vistagen Therapeutics, Inc. report Q3 2025 earnings?
Vistagen Therapeutics, Inc. (VTGN) reported Q3 2025 earnings on November 13, 2025 after market close.
What were Vistagen Therapeutics, Inc.'s Q3 2025 revenue and EPS?
Vistagen Therapeutics, Inc. reported revenue of $258.0K and eps of $-0.54 for Q3 2025.
Did Vistagen Therapeutics, Inc. beat estimates in Q3 2025?
Revenue beat the consensus estimate of $145.8K by $112.2K. EPS missed the consensus estimate of $-0.51 by $0.03.
How did Vistagen Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 41.0% from $183.0K a year earlier and eps declined 28.6% from $-0.42.
Where can I find Vistagen Therapeutics, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-052077) and the 10-Q periodic report (0001628280-25-052079) directly on SEC EDGAR. The filing index links above go to sec.gov.